Bivalirudin versus Heparin Monotherapy in Percutaneous Coronary Intervention Patients: a Comparison of Acute Adverse Outcomes and Long Term Mortality

被引：0
|
作者：
Ephrem, Georges
Kim, Michael C.
Jauhar, Rajiv
Meraj, Perwaiz M.
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Anticoagulants; Percutaneous coronary intervention (PCI); Glycoprotein iib/iiia platelet inhibitors; Outcomes;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13072
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving Bivalirudin versus Unfractionated heparin versus Clopidogrel pretreatment and Bivalirudin
    Anand, Sunil X.
    Kim, Michael C.
    Kamran, Mazullah
    Sharma, Samin K.
    Kini, Annapoorna S.
    Fareed, Jawed
    Hoppensteadt, Debra A.
    Carbon, Frank
    Cavusoglu, Erdal
    Varon, David
    Viles-Gonzalez, Juan F.
    Badimon, Juan J.
    Marmur, Jonathan D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (03): : 417 - 424
  • [22] Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes
    Farag, Mohamed
    Gorog, Diana A.
    Prasad, Abhiram
    Srinivasan, Manivannan
    OPEN HEART, 2015, 2 (01):
  • [23] OUTCOMES OF BIVALIRUDIN VERSUS HEPARIN ALONE IN PERCUTEANEOUS CORONARY INTERVENTION
    Chaudry, H. I.
    Andrus, B. W.
    Bhatt, D.
    DeVries, J. T.
    CARDIOLOGY, 2015, 131 : 223 - 223
  • [24] Heparin Versus Bivalirudin Monotherapy in the Setting of Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction
    Faulkenberg, Kathleen D.
    Beavers, Janna C.
    Finks, Shannon W.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (02) : 141 - 151
  • [25] Heparin and Bivalirudin in Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Review Article
    Wang, Guiping
    Qi, Kaijie
    Li, Xuyang
    Zuo, Shuping
    Zhang, Ruolin
    Zhao, Yanan
    Sun, Suya
    Zhang, Juanjuan
    Liu, Xiaokun
    CARDIOVASCULAR THERAPEUTICS, 2024, 2024 (01)
  • [26] A meta-analysis of bivalirudin compared with unfractionated heparin in patients with acute coronary syndromes undergoing urgent percutaneous coronary intervention versus elective percutaneous coronary intervention
    Liu, Yulong
    Li, Liang
    Wang, Mei
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C111 - C111
  • [27] BIVALIRUDIN VERSUS UNFRACTIONED HEPARIN: DIFFERENTIAL BENEFIT ACROSS THE SPECTRUM OF PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES
    Farag, Mohamed
    Gorog, Diana
    Srinivasan, Manivannan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A118 - A118
  • [28] Impact of Major Bleeding on Long-Term Mortality in Anemic Versus Nonanemic Patients Undergoing Percutaneous Coronary Intervention Using Bivalirudin
    Ali, Ziad A.
    Poludasu, Shyam
    Qureshi, Yasir H.
    Krishnan, Prakash
    Ali, Ayyaz A.
    Tatonetti, Nicholas
    Downey, Peter
    Zalewski, Adrian
    Nazif, Tamim
    George, Isaac
    Mandava, Anupa
    Baber, Usman
    Dangas, George
    Mehran, Roxana
    Kini, Annapoorna S.
    Sharma, Samin K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (09): : 1481 - 1486
  • [29] Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART study
    Grimfjard, Per
    Erlinge, David
    Koul, Sasha
    Lagerqvist, Bo
    Svennblad, Bodil
    Varenhorst, Christoph
    James, Stefan K.
    EUROINTERVENTION, 2017, 12 (16) : 2009 - 2017
  • [30] Bivalirudin Versus Heparin Alone in Low-Risk Percutaneous Coronary Intervention: Indirect Versus Direct Comparison
    Kaul, Sanjay
    Azarbal, Babak
    Shah, Prediman K.
    Diamond, George A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A343 - A343
12345